Mainstream

Xtant Medical outlines 8–11% revenue growth target for 2025 as company completes vertical integration and launches new products

Xtant Medical outlines 8–11% revenue growth target for 2025 as company completes vertical integration and launches new products

Post ContentxtntRead More

You might also be interested in reading E-L Financial Corporation Limited PFD 1ST SER 3 declares CAD 0.3438 dividend.

May 13, 2025
In Mainstream